Publication: 217

Randomized Phase II Study of Gemcitabine Administered at a Fixed Dose Rate or in Combination With Cisplatin, Docetaxel, or Irinotecan in Patients With Metastatic Pancreatic Cancer: CALGB 89904
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 27 (33) 5506-5512
Year:
2009
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA031946, U10 CA033601, CA31946, CA33601  
Corr. Author:
 
Authors:
                     
Networks:
 
Study
CALGB-89904
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
Gic26, Original Reports, Gastrointestinal Cancer